mRNA-Based Viral Vaccines: Revolutionizing Prophylaxis through Biotechnological Innovations and Virological Insights

Abstract

The post-genomic and post-pandemic era has brought about a paradigm shift in the realm of vaccinology, which has triggered a transition from empirical whole-pathogen strategies to rational information-driven molecular design. The sudden and spectacular rise of messenger RNA (mRNA) vaccines is a disruptive prophylactic technology, whose efficacy has been unequivocally proven on a global platform during the COVID-19 pandemic. The unprecedented success of mRNA vaccines is a direct result of the strategic convergence of synthetic biology, structural virology, and immunoengineering. As a form of programmable biological software, mRNA vaccines provide a precise set of genetic instructions for the in vivo production of antigens, thereby inducing a coordinated humoral and cellular immune response. The review article will cover the multi-disciplinary underpinnings of the technology, its translation from bench to global platform, and the future frontiers that will be enabled by the strategic integration of artificial intelligence and synthetic biology, which will firmly establish mRNA vaccinology as a cornerstone of 21st-century medicine.